drugset / Trial / NCT00150436

To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia.

NCT00150436

Phase 3 Completed 276 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate long-term safety and efficacy of pregabalin in patients with postherpetic neuralgia.

Timeline

Start
2002-02
Primary completion
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule

Indications